Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Depreciation & Amortization (CF): 2012-2025

Historic Depreciation & Amortization (CF) for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $5.3 million.

  • Veracyte's Depreciation & Amortization (CF) fell 10.41% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year decrease of 4.98%. This contributed to the annual value of $23.5 million for FY2024, which is 13.72% down from last year.
  • According to the latest figures from Q3 2025, Veracyte's Depreciation & Amortization (CF) is $5.3 million, which was down 4.06% from $5.5 million recorded in Q2 2025.
  • Veracyte's Depreciation & Amortization (CF)'s 5-year high stood at $7.3 million during Q3 2023, with a 5-year trough of $2.5 million in Q1 2021.
  • In the last 3 years, Veracyte's Depreciation & Amortization (CF) had a median value of $5.9 million in 2024 and averaged $6.1 million.
  • As far as peak fluctuations go, Veracyte's Depreciation & Amortization (CF) spiked by 216.25% in 2021, and later fell by 19.73% in 2024.
  • Over the past 5 years, Veracyte's Depreciation & Amortization (CF) (Quarterly) stood at $6.4 million in 2021, then rose by 2.37% to $6.6 million in 2022, then dropped by 3.36% to $6.3 million in 2023, then decreased by 1.31% to $6.3 million in 2024, then fell by 10.41% to $5.3 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $5.3 million for Q3 2025, versus $5.5 million for Q2 2025 and $5.4 million for Q1 2025.